Sinai山启动了AI中心,以加快癌症等疾病的药物开发。 Mount Sinai launches AI center to speed up drug development for diseases like cancer.

位于西奈山的Icahn医学院启动了AI小型分子药物发现中心,以利用人工智能加速药物开发。 The Icahn School of Medicine at Mount Sinai has launched an AI Small Molecule Drug Discovery Center to accelerate drug development using artificial intelligence. 该中心将侧重于设计新药物,优化现有药物,预测药物的相互作用,以期使病人更快地治疗癌症和神经退化性疾病等紧急疾病。 This center will focus on designing new drugs, optimizing existing ones, and predicting drug interactions, aiming to bring treatments to patients faster for urgent diseases like cancer and neurodegenerative disorders. 这一举措可以大大加快药物发现进程,提高确定有效新药物的精确度。 The initiative could significantly speed up the drug discovery process and enhance precision in identifying effective new drugs.